News Canada Inc.

March 08, 2005 12:17 ET

Landmark trial shows patients benefit from intensive cholesterol-low

Attention: Assignment Editor, Health/Medical Editor, News Editor TORONTO, ONTARIO--(CCNMatthews - March 8, 2005) - News Canada Satellite Newsfeed - Tuesday March 8, 2005

Video B-Roll Available Via Satellite at 14:00 - 14:30 firm, Eastern

(NC839) Landmark trial shows patients benefit from intensive cholesterol-lowering

B-roll Description:
Study results from the Treating to New Targets (TNT) study published in today's online issue of the New England Journal of Medicine demonstrate that patients with coronary heart disease who took  Lipitor (atorvastatin  calcium) and lowered their cholesterol to well below recommended levels experienced significantly fewer heart attacks and strokes than those who only lowered their cholesterol to recommended levels, according to data presented today at the annual meeting of the American College of Cardiology.  
 
B-roll clips include Canadian TNT investigators:
Dr. Lawrence Leiter, Head of Endocrinology at St. Michael's Hospital in Toronto
Dr. Jacques Genest, Professor of Medicine and Head of Cardiology at McGill University in Montreal   

SATELLITE FEED CO-ORDINATES:
Anik F2, C-Band, Transponder 8B @111.1 West
Vertical Polarization, D/L Freq. 4020 MHz. Ch. 14
Audio subcarriers 6.8 left, 6.2 right
Telesat Confirmation #206307 - Magnacom

Also Available at Toronto T.O.C.:
PGAD 14:30-15:00 Eastern, Tuesday, March 8, 2005
Magnacom NOVSXS 225340-002 (SDI Router Position#42) /For further information: Cathy Dillon at News Canada Inc. Tel: 1-866-639-7226 ext 202 email: cdillon@newscanada.com/ IN: HEALTH

Contact Information

  • Cathy Dillon, Broadcast Media Manager
    Primary Phone: 866-639-7226 ext. 202
    Secondary Phone: 416-599-9900 ext. 202
    Toll-Free: 866-639-7226
    E-mail: cdillon@newscanada.com